Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Establishment and Genetic Landscape of Precancer Cell Model Systems from the Head and Neck Mucosal Lining.

de Boer DV, Brink A, Buijze M, Stigter-van Walsum M, Hunter KD, Ylstra B, Bloemena E, Leemans CR, Brakenhoff RH.

Mol Cancer Res. 2018 Sep 17. doi: 10.1158/1541-7786.MCR-18-0445. [Epub ahead of print]

PMID:
30224542
2.

Surgical quality assurance in head and neck cancer trials: an EORTC Head and Neck Cancer Group position paper based on the EORTC 1420 'Best of' and 24954 'larynx preservation' study.

Simon C, Caballero C, Gregoire V, Thurnher D, Koivunen P, Ceruse P, Spriano G, Nicolai P, Licitra L, Machiels JP, Hamoir M, Andry G, Mehanna H, Hunter KD, Dietz A, René Leemans C.

Eur J Cancer. 2018 Sep 11;103:69-77. doi: 10.1016/j.ejca.2018.07.140. [Epub ahead of print] Review.

PMID:
30216847
3.

The IL-1/IL-1R axis induces greater fibroblast-derived chemokine release in human papillomavirus-negative compared to positive oropharyngeal cancer.

Al-Sahaf S, Hunter KD, Bolt R, Ottewell PD, Murdoch C.

Int J Cancer. 2018 Sep 7. doi: 10.1002/ijc.31852. [Epub ahead of print]

PMID:
30191960
4.

Targeting HOX-PBX interactions causes death in oral potentially malignant and squamous carcinoma cells but not normal oral keratinocytes.

Platais C, Radhakrishnan R, Niklander SE, Morgan R, Lambert DW, Hunter KD.

BMC Cancer. 2018 Jul 6;18(1):723. doi: 10.1186/s12885-018-4622-0.

5.

Unicystic ameloblastoma: Analysis of 370 cases in a single center in Sri Lanka.

Siriwardena BSMS, Tennakoon TMPB, Hunter KD, Tilakaratne WM.

J Oral Pathol Med. 2018 Aug;47(7):706-709. doi: 10.1111/jop.12740. Epub 2018 Jun 20.

PMID:
29858565
6.

Hypoxia modulates CCR7 expression in head and neck cancers.

Basheer HA, Pakanavicius E, Cooper PA, Shnyder SD, Martin L, Hunter KD, Vinader V, Afarinkia K.

Oral Oncol. 2018 May;80:64-73. doi: 10.1016/j.oraloncology.2018.03.014. Epub 2018 Apr 4.

PMID:
29706190
7.

Altered Toll-like receptor expression and function in HPV-associated oropharyngeal carcinoma.

Tobouti PL, Bolt R, Radhakrishnan R, de Sousa SCOM, Hunter KD.

Oncotarget. 2017 Jul 4;9(1):236-248. doi: 10.18632/oncotarget.18959. eCollection 2018 Jan 2.

8.

HPV-negative, but not HPV-positive, oropharyngeal carcinomas induce fibroblasts to support tumour invasion through micro-environmental release of HGF and IL-6.

Bolt R, Foran B, Murdoch C, Lambert DW, Thomas S, Hunter KD.

Carcinogenesis. 2018 Feb 9;39(2):170-179. doi: 10.1093/carcin/bgx130.

PMID:
29140428
9.

Using virtual microscopy to deliver an integrated oral pathology course for undergraduate dental students.

Brierley DJ, Speight PM, Hunter KD, Farthing P.

Br Dent J. 2017 Jul 21;223(2):115-120. doi: 10.1038/sj.bdj.2017.626.

PMID:
28729584
10.

DNA damage marker phosphorylated histone H2AX is a potential predictive marker for progression of epithelial dysplasia of the oral cavity.

Leung EY, McMahon JD, McLellan DR, Syyed N, McCarthy CE, Nixon C, Orange C, Brock C, Hunter KD, Adams PD.

Histopathology. 2017 Oct;71(4):522-528. doi: 10.1111/his.13260. Epub 2017 Jul 21.

11.

Targeting HOX/PBX dimers in cancer.

Morgan R, El-Tanani M, Hunter KD, Harrington KJ, Pandha HS.

Oncotarget. 2017 May 9;8(19):32322-32331. doi: 10.18632/oncotarget.15971. Review.

12.

HOPX functions as a tumour suppressor in head and neck cancer.

Yap LF, Lai SL, Patmanathan SN, Gokulan R, Robinson CM, White JB, Chai SJ, Rajadurai P, Prepageran N, Liew YT, Lopes V, Wei W, Hollows RJ, Murray PG, Lambert DW, Hunter KD, Paterson IC.

Sci Rep. 2016 Dec 9;6:38758. doi: 10.1038/srep38758.

13.

Oral malignancy and premalignancy.

Hegarty AM, Hunter KD.

Br J Hosp Med (Lond). 2016 Apr;77(4):232-9. doi: 10.12968/hmed.2016.77.4.232. Review.

PMID:
27071430
14.

Immunoexpression of hoxb7 and hoxb9 in salivary gland tumours.

Fonseca FP, Bingle L, Santos-Silva AR, Lopes MA, Coletta RD, de Andrade BA, Mariano FV, Kowalski LP, Rangel AL, Martins MD, Meurer L, Hunter KD, Speight PM, Vargas PA.

J Oral Pathol Med. 2016 Oct;45(9):672-681. doi: 10.1111/jop.12438. Epub 2016 Mar 15.

PMID:
26991799
15.

The role of HOX genes in head and neck squamous cell carcinoma.

Platais C, Hakami F, Darda L, Lambert DW, Morgan R, Hunter KD.

J Oral Pathol Med. 2016 Apr;45(4):239-47. doi: 10.1111/jop.12388. Epub 2015 Dec 14. Review.

PMID:
26661059
16.

Progressive bilateral enlargement and pain affecting the parotid salivary glands: an unusual histologic finding.

Cottom H, O'Neill N, Kumar A, Hunter KD.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2015 Dec;120(6):664-9. doi: 10.1016/j.oooo.2015.07.004. Epub 2015 Jul 11. No abstract available.

PMID:
26324748
17.

Rapid modification of the bone microenvironment following short-term treatment with Cabozantinib in vivo.

Haider MT, Hunter KD, Robinson SP, Graham TJ, Corey E, Dear TN, Hughes R, Brown NJ, Holen I.

Bone. 2015 Dec;81:581-592. doi: 10.1016/j.bone.2015.08.003. Epub 2015 Aug 14.

18.

Rapidly-growing buccal mass in a 6-month-old infant.

Kumar A, Brierley D, Hunter KD, Lee N.

Br J Oral Maxillofac Surg. 2015 Nov;53(9):888-90. doi: 10.1016/j.bjoms.2015.07.006. Epub 2015 Aug 3.

PMID:
26250364
19.

The role of HOXB9 and miR-196a in head and neck squamous cell carcinoma.

Darda L, Hakami F, Morgan R, Murdoch C, Lambert DW, Hunter KD.

PLoS One. 2015 Apr 10;10(4):e0122285. doi: 10.1371/journal.pone.0122285. eCollection 2015.

20.

Polymorphous low-grade adenocarcinoma of the upper lip: 11 cases of an uncommon diagnosis.

Fonseca FP, Brierley D, Wright JM, Santos-Silva AR, Almeida OP, Rocha AC, Van Heerden WF, Hunter KD.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2015 May;119(5):566-71. doi: 10.1016/j.oooo.2015.01.001. Epub 2015 Jan 16.

21.

Effects of recombinant human bone morphogenetic protein 7 (rhBMP-7) on the behaviour of oral squamous cell carcinoma: a preliminary in vitro study.

Lappin DF, Abu-Serriah M, Hunter KD.

Br J Oral Maxillofac Surg. 2015 Feb;53(2):158-63. doi: 10.1016/j.bjoms.2014.11.002. Epub 2014 Dec 2.

PMID:
25480012
22.

The diagnostic usefulness of immunohistochemistry for odontogenic lesions.

Hunter KD, Speight PM.

Head Neck Pathol. 2014 Dec;8(4):392-9. doi: 10.1007/s12105-014-0582-0. Epub 2014 Nov 20. Review.

23.

Stromal myofibroblasts in squamous cell carcinoma of the tongue in young patients - a multicenter collaborative study.

Fonseca FP, Coletta RD, Azevedo MB, Prado Ribeiro AC, Pires Soubhia AM, Miyahara GI, Carlos R, Farthing P, Hunter KD, Speight PM, Vargas PA, Almeida OP, Lopes MA, Santos-Silva AR.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2014 Oct;118(4):483-9. doi: 10.1016/j.oooo.2014.07.012. Epub 2014 Aug 2.

24.

The roles of HOXD10 in the development and progression of head and neck squamous cell carcinoma (HNSCC).

Hakami F, Darda L, Stafford P, Woll P, Lambert DW, Hunter KD.

Br J Cancer. 2014 Aug 12;111(4):807-16. doi: 10.1038/bjc.2014.372. Epub 2014 Jul 10.

25.

Peritrabecular clefting in fibrous dysplasia of the jaws: how soon is now?

Prado Ribeiro AC, Carlos R, Speight PM, Hunter KD, Santos-Silva AR, Almeida OP, Vargas PA.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Aug;116(2):265. doi: 10.1016/j.oooo.2013.04.005. Epub 2013 May 31. No abstract available.

PMID:
23731662
26.

An update on the clinical pathology of oral precancer and cancer.

Hunter KD, Yeoman CM.

Dent Update. 2013 Mar;40(2):120-2, 125-6. Review.

PMID:
23600036
27.

Is next-generation sequencing an important tool in HPV subtype diagnosis?

Wood HM, Bolt R, Hunter KD.

Expert Rev Mol Diagn. 2012 Sep;12(7):663-5. doi: 10.1586/erm.12.67. No abstract available.

PMID:
23153231
28.

Peritrabecular clefting in fibrous dysplasia of the jaws: an important histopathologic feature for differentiating fibrous dysplasia from central ossifying fibroma.

Prado Ribeiro AC, Carlos R, Speight PM, Hunter KD, Santos-Silva AR, de Almeida OP, Vargas PA.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2012 Oct;114(4):503-8. doi: 10.1016/j.oooo.2012.06.014.

29.

IgG4-related sclerosing disease clinically mimicking oral squamous cell carcinoma.

Khurram SA, Fernando M, Smith AT, Hunter KD.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Feb;115(2):e48-51. doi: 10.1016/j.oooo.2012.04.011. Epub 2012 Aug 15.

30.

Endothelin-1 stimulates oral fibroblasts to promote oral cancer invasion.

Hinsley EE, Kumar S, Hunter KD, Whawell SA, Lambert DW.

Life Sci. 2012 Oct 15;91(13-14):557-61. doi: 10.1016/j.lfs.2012.04.001. Epub 2012 Apr 13.

31.

Mandibular reconstruction in the rabbit using beta-tricalcium phosphate (β-TCP) scaffolding and recombinant bone morphogenetic protein 7 (rhBMP-7) - histological, radiographic and mechanical evaluations.

Busuttil Naudi K, Ayoub A, McMahon J, Di Silvio L, Lappin D, Hunter KD, Barbenel J.

J Craniomaxillofac Surg. 2012 Dec;40(8):e461-9. doi: 10.1016/j.jcms.2012.03.005. Epub 2012 Apr 15.

PMID:
22507295
32.

Oestrogen receptor β in adenoid cystic carcinoma of salivary glands.

Marques YM, Giudice FS, Freitas VM, Abreu e Lima Mdo C, Hunter KD, Speight PM, Machado de Sousa SC.

Histopathology. 2012 Mar;60(4):609-16. doi: 10.1111/j.1365-2559.2011.04095.x. Epub 2012 Jan 19.

PMID:
22260414
33.

Evaluating the use of optical coherence tomography for the detection of epithelial cancers in vitro.

Smith LE, Hearnden V, Lu Z, Smallwood R, Hunter KD, Matcher SJ, Thornhill MH, Murdoch C, MacNeil S.

J Biomed Opt. 2011 Nov;16(11):116015. doi: 10.1117/1.3652708.

34.

High incidences of DNA ploidy abnormalities in tongue squamous cell carcinoma of young patients: an international collaborative study.

Santos-Silva AR, Ribeiro AC, Soubhia AM, Miyahara GI, Carlos R, Speight PM, Hunter KD, Torres-Rendon A, Vargas PA, Lopes MA.

Histopathology. 2011 Jun;58(7):1127-35. doi: 10.1111/j.1365-2559.2011.03863.x.

PMID:
21707713
35.

Endothelin-1 stimulates motility of head and neck squamous carcinoma cells by promoting stromal-epithelial interactions.

Hinsley EE, Hunt S, Hunter KD, Whawell SA, Lambert DW.

Int J Cancer. 2012 Jan 1;130(1):40-7. doi: 10.1002/ijc.25968. Epub 2011 Apr 13.

36.

Crystal storing histiocytosis of the tongue as the initial presentation of multiple myeloma.

Khurram SA, McPhaden A, Hislop WS, Hunter KD.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011 Apr;111(4):494-6. doi: 10.1016/j.tripleo.2010.12.019.

PMID:
21420638
37.

CD56 (NCAM) expression in ameloblastomas and other odontogenic lesions.

Cairns L, Naidu A, Robinson CM, Sloan P, Wright JM, Hunter KD.

Histopathology. 2010 Oct;57(4):544-8. doi: 10.1111/j.1365-2559.2010.03658.x. Epub 2010 Sep 28.

PMID:
20875069
38.

Localized idiopathic internal resorption in the primary dentition.

Lad N, Hosey MT, Hunter KD.

J Clin Pediatr Dent. 2010 Summer;34(4):339-41.

PMID:
20831137
39.

A retrospective analysis of histological prognostic factors for the development of lymph node metastases from auricular squamous cell carcinoma.

Clark RR, Soutar DS, Hunter KD.

Histopathology. 2010 Jul;57(1):138-46. doi: 10.1111/j.1365-2559.2010.03593.x.

PMID:
20653785
40.

Sentinel node biopsy in head and neck squamous cell cancer: 5-year follow-up of a European multicenter trial.

Alkureishi LW, Ross GL, Shoaib T, Soutar DS, Robertson AG, Thompson R, Hunter KD, Sorensen JA, Thomsen J, Krogdahl A, Alvarez J, Barbier L, Santamaria J, Poli T, Sesenna E, Kovács AF, Grünwald F, Barzan L, Sulfaro S, Alberti F.

Ann Surg Oncol. 2010 Sep;17(9):2459-64. doi: 10.1245/s10434-010-1111-3. Epub 2010 Jun 15.

PMID:
20552410
41.

Spectral clustering of microarray data elucidates the roles of microenvironment remodeling and immune responses in survival of head and neck squamous cell carcinoma.

Thurlow JK, Peña Murillo CL, Hunter KD, Buffa FM, Patiar S, Betts G, West CM, Harris AL, Parkinson EK, Harrison PR, Ozanne BW, Partridge M, Kalna G.

J Clin Oncol. 2010 Jun 10;28(17):2881-8. doi: 10.1200/JCO.2009.24.8724. Epub 2010 May 10. Erratum in: J Clin Oncol. 2010 Oct 20;28(30):4664.

PMID:
20458058
42.

Should we be surprised at the paucity of response to EGFR inhibitors?

Gusterson BA, Hunter KD.

Lancet Oncol. 2009 May;10(5):522-7. doi: 10.1016/S1470-2045(09)70034-8. Review.

PMID:
19410197
43.

Micrometastases and isolated tumour cells in sentinel lymph nodes in oral and oropharyngeal squamous cell carcinoma.

Atula T, Hunter KD, Cooper LA, Shoaib T, Ross GL, Soutar DS.

Eur J Surg Oncol. 2009 May;35(5):532-8. doi: 10.1016/j.ejso.2008.12.014. Epub 2009 Jan 25.

PMID:
19171449
44.

The clinical content of preconception care: infectious diseases in preconception care.

Coonrod DV, Jack BW, Stubblefield PG, Hollier LM, Boggess KA, Cefalo R, Cox SN, Dunlop AL, Hunter KD, Prasad MR, Lu MC, Conry JA, Gibbs RS, Hogan VK.

Am J Obstet Gynecol. 2008 Dec;199(6 Suppl 2):S296-309. doi: 10.1016/j.ajog.2008.08.062.

PMID:
19081424
45.

The clinical content of preconception care: immunizations as part of preconception care.

Coonrod DV, Jack BW, Boggess KA, Long R, Conry JA, Cox SN, Cefalo R, Hunter KD, Pizzica A, Dunlop AL.

Am J Obstet Gynecol. 2008 Dec;199(6 Suppl 2):S290-5. doi: 10.1016/j.ajog.2008.08.061.

PMID:
19081423
46.

Keratoacanthoma of the gingiva--a pathological conundrum.

Naudi KB, Critchlow HA, Hunter KD.

Oral Oncol. 2009 Jan;45(1):e9-10. doi: 10.1016/j.oraloncology.2008.03.011. Epub 2008 May 16. No abstract available.

PMID:
18485793
47.

The atypical chemokine receptor D6 suppresses the development of chemically induced skin tumors.

Nibbs RJ, Gilchrist DS, King V, Ferra A, Forrow S, Hunter KD, Graham GJ.

J Clin Invest. 2007 Jul;117(7):1884-92.

48.

Ligneous alveolar gingivitis in the absence of plasminogen deficiency.

Naudi KB, Hunter KD, MacDonald DG, Felix DH.

J Oral Pathol Med. 2006 Nov;35(10):636-8.

PMID:
17032399
49.

Divergent routes to oral cancer.

Hunter KD, Thurlow JK, Fleming J, Drake PJ, Vass JK, Kalna G, Higham DJ, Herzyk P, Macdonald DG, Parkinson EK, Harrison PR.

Cancer Res. 2006 Aug 1;66(15):7405-13.

50.

Profiling early head and neck cancer.

Hunter KD, Parkinson EK, Harrison PR.

Nat Rev Cancer. 2005 Feb;5(2):127-35. doi: 10.1038/nrc1549. Review.

PMID:
15685196

Supplemental Content

Loading ...
Support Center